Emerald Resources NL (EMR.AX) Stock Competitors & Peer Comparison
See (EMR.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Gold Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMR.AX | A$5.46 | -4.21% | 3.8B | 38.00 | A$0.15 | N/A |
| NEM.AX | A$137.61 | -3.21% | 150.6B | 12.04 | A$11.71 | +1.05% |
| NST.AX | A$20.66 | -6.77% | 31.1B | 17.86 | A$1.22 | +2.53% |
| EVN.AX | A$11.94 | -6.86% | 25.6B | 20.11 | A$0.63 | +2.62% |
| NCM.AX | A$23.35 | -1.27% | 20.9B | 17.56 | A$1.33 | +2.61% |
| AGG.AX | A$6.51 | -3.27% | 13.9B | 50.08 | A$0.13 | +1.95% |
| GGP.AX | A$11.26 | -4.33% | 7.9B | 11.77 | A$1.00 | N/A |
| GMD.AX | A$5.78 | -8.11% | 6.9B | 22.85 | A$0.26 | N/A |
| PRU.AX | A$4.97 | -4.79% | 6.9B | 18.06 | A$0.29 | +1.93% |
| CMM.AX | A$13.65 | -2.71% | 6.5B | 32.02 | A$0.44 | +0.35% |
Stock Comparison
EMR.AX vs NEM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, NEM.AX has a market cap of 150.6B. Regarding current trading prices, EMR.AX is priced at A$5.46, while NEM.AX trades at A$137.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas NEM.AX's P/E ratio is 12.04. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NEM.AX's ROE of +0.25%. Regarding short-term risk, EMR.AX is more volatile compared to NEM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NEM.AX's competition here
EMR.AX vs NST.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, NST.AX has a market cap of 31.1B. Regarding current trading prices, EMR.AX is priced at A$5.46, while NST.AX trades at A$20.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas NST.AX's P/E ratio is 17.86. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NST.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is less volatile compared to NST.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check NST.AX's competition here
EMR.AX vs EVN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, EVN.AX has a market cap of 25.6B. Regarding current trading prices, EMR.AX is priced at A$5.46, while EVN.AX trades at A$11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas EVN.AX's P/E ratio is 20.11. In terms of profitability, EMR.AX's ROE is +0.15%, compared to EVN.AX's ROE of +0.25%. Regarding short-term risk, EMR.AX is more volatile compared to EVN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check EVN.AX's competition here
EMR.AX vs NCM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, NCM.AX has a market cap of 20.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while NCM.AX trades at A$23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas NCM.AX's P/E ratio is 17.56. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NCM.AX's ROE of +0.07%. Regarding short-term risk, EMR.AX is more volatile compared to NCM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NCM.AX's competition here
EMR.AX vs AGG.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, AGG.AX has a market cap of 13.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while AGG.AX trades at A$6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas AGG.AX's P/E ratio is 50.08. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AGG.AX's ROE of +0.24%. Regarding short-term risk, EMR.AX is more volatile compared to AGG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AGG.AX's competition here
EMR.AX vs GGP.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GGP.AX has a market cap of 7.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while GGP.AX trades at A$11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GGP.AX's P/E ratio is 11.77. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GGP.AX's ROE of +0.42%. Regarding short-term risk, EMR.AX is more volatile compared to GGP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GGP.AX's competition here
EMR.AX vs GMD.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GMD.AX has a market cap of 6.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while GMD.AX trades at A$5.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GMD.AX's P/E ratio is 22.85. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GMD.AX's ROE of +0.29%. Regarding short-term risk, EMR.AX is more volatile compared to GMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GMD.AX's competition here
EMR.AX vs PRU.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, PRU.AX has a market cap of 6.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while PRU.AX trades at A$4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas PRU.AX's P/E ratio is 18.06. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PRU.AX's ROE of +0.12%. Regarding short-term risk, EMR.AX is more volatile compared to PRU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check PRU.AX's competition here
EMR.AX vs CMM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, CMM.AX has a market cap of 6.5B. Regarding current trading prices, EMR.AX is priced at A$5.46, while CMM.AX trades at A$13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas CMM.AX's P/E ratio is 32.02. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CMM.AX's ROE of +0.23%. Regarding short-term risk, EMR.AX is more volatile compared to CMM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check CMM.AX's competition here
EMR.AX vs DEG.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, DEG.AX has a market cap of 5.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while DEG.AX trades at A$2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas DEG.AX's P/E ratio is -246.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DEG.AX's ROE of -0.02%. Regarding short-term risk, EMR.AX is less volatile compared to DEG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DEG.AX's competition here
EMR.AX vs RMS.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RMS.AX has a market cap of 5.9B. Regarding current trading prices, EMR.AX is priced at A$5.46, while RMS.AX trades at A$2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RMS.AX's P/E ratio is 8.92. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RMS.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is more volatile compared to RMS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RMS.AX's competition here
EMR.AX vs VAU.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, VAU.AX has a market cap of 5.3B. Regarding current trading prices, EMR.AX is priced at A$5.46, while VAU.AX trades at A$4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas VAU.AX's P/E ratio is -314.98. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VAU.AX's ROE of +0.04%. Regarding short-term risk, EMR.AX is more volatile compared to VAU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check VAU.AX's competition here
EMR.AX vs RRL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RRL.AX has a market cap of 5.1B. Regarding current trading prices, EMR.AX is priced at A$5.46, while RRL.AX trades at A$6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RRL.AX's P/E ratio is 10.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RRL.AX's ROE of +0.28%. Regarding short-term risk, EMR.AX is more volatile compared to RRL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RRL.AX's competition here
EMR.AX vs WGX.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, WGX.AX has a market cap of 4.7B. Regarding current trading prices, EMR.AX is priced at A$5.46, while WGX.AX trades at A$4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas WGX.AX's P/E ratio is 12.24. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WGX.AX's ROE of +0.12%. Regarding short-term risk, EMR.AX is more volatile compared to WGX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check WGX.AX's competition here
EMR.AX vs GOR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GOR.AX has a market cap of 3.8B. Regarding current trading prices, EMR.AX is priced at A$5.46, while GOR.AX trades at A$3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GOR.AX's P/E ratio is 18.32. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GOR.AX's ROE of +0.15%. Regarding short-term risk, EMR.AX is more volatile compared to GOR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GOR.AX's competition here
EMR.AX vs WAF.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, WAF.AX has a market cap of 3.4B. Regarding current trading prices, EMR.AX is priced at A$5.46, while WAF.AX trades at A$2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas WAF.AX's P/E ratio is 6.72. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WAF.AX's ROE of +0.42%. Regarding short-term risk, EMR.AX is less volatile compared to WAF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WAF.AX's competition here
EMR.AX vs SSR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, SSR.AX has a market cap of 3.2B. Regarding current trading prices, EMR.AX is priced at A$5.46, while SSR.AX trades at A$15.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas SSR.AX's P/E ratio is -7.30. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SSR.AX's ROE of -0.08%. Regarding short-term risk, EMR.AX is more volatile compared to SSR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SSR.AX's competition here
EMR.AX vs SPR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, SPR.AX has a market cap of 2.8B. Regarding current trading prices, EMR.AX is priced at A$5.46, while SPR.AX trades at A$2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas SPR.AX's P/E ratio is -35.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SPR.AX's ROE of -0.41%. Regarding short-term risk, EMR.AX is less volatile compared to SPR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SPR.AX's competition here
EMR.AX vs RED.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RED.AX has a market cap of 2.3B. Regarding current trading prices, EMR.AX is priced at A$5.46, while RED.AX trades at A$0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RED.AX's P/E ratio is 17.10. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RED.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is more volatile compared to RED.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RED.AX's competition here
EMR.AX vs OBM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, OBM.AX has a market cap of 2.3B. Regarding current trading prices, EMR.AX is priced at A$5.46, while OBM.AX trades at A$1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas OBM.AX's P/E ratio is 16.21. In terms of profitability, EMR.AX's ROE is +0.15%, compared to OBM.AX's ROE of +0.68%. Regarding short-term risk, EMR.AX is more volatile compared to OBM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check OBM.AX's competition here
EMR.AX vs RSG.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RSG.AX has a market cap of 2.1B. Regarding current trading prices, EMR.AX is priced at A$5.46, while RSG.AX trades at A$0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RSG.AX's P/E ratio is 505.08. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RSG.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is more volatile compared to RSG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RSG.AX's competition here
EMR.AX vs BGL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BGL.AX has a market cap of 2B. Regarding current trading prices, EMR.AX is priced at A$5.46, while BGL.AX trades at A$1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BGL.AX's P/E ratio is -32.10. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BGL.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is less volatile compared to BGL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BGL.AX's competition here
EMR.AX vs PDI.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, PDI.AX has a market cap of 2B. Regarding current trading prices, EMR.AX is priced at A$5.46, while PDI.AX trades at A$0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas PDI.AX's P/E ratio is -90.36. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PDI.AX's ROE of -0.08%. Regarding short-term risk, EMR.AX is less volatile compared to PDI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PDI.AX's competition here
EMR.AX vs ALK.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, ALK.AX has a market cap of 2B. Regarding current trading prices, EMR.AX is priced at A$5.46, while ALK.AX trades at A$1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas ALK.AX's P/E ratio is 10.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ALK.AX's ROE of +0.13%. Regarding short-term risk, EMR.AX is more volatile compared to ALK.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ALK.AX's competition here
EMR.AX vs SLR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, SLR.AX has a market cap of 1.5B. Regarding current trading prices, EMR.AX is priced at A$5.46, while SLR.AX trades at A$1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas SLR.AX's P/E ratio is 15.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SLR.AX's ROE of +0.03%. Regarding short-term risk, EMR.AX is more volatile compared to SLR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SLR.AX's competition here
EMR.AX vs KCN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, KCN.AX has a market cap of 1.4B. Regarding current trading prices, EMR.AX is priced at A$5.46, while KCN.AX trades at A$5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas KCN.AX's P/E ratio is 14.69. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KCN.AX's ROE of +0.31%. Regarding short-term risk, EMR.AX is more volatile compared to KCN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check KCN.AX's competition here
EMR.AX vs PNR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, PNR.AX has a market cap of 931.4M. Regarding current trading prices, EMR.AX is priced at A$5.46, while PNR.AX trades at A$2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas PNR.AX's P/E ratio is 16.88. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PNR.AX's ROE of +0.20%. Regarding short-term risk, EMR.AX is less volatile compared to PNR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PNR.AX's competition here
EMR.AX vs WIA.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, WIA.AX has a market cap of 859.4M. Regarding current trading prices, EMR.AX is priced at A$5.46, while WIA.AX trades at A$0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas WIA.AX's P/E ratio is -56.74. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WIA.AX's ROE of -0.18%. Regarding short-term risk, EMR.AX is more volatile compared to WIA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check WIA.AX's competition here
EMR.AX vs TIE.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TIE.AX has a market cap of 776.2M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TIE.AX trades at A$0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TIE.AX's P/E ratio is -9.67. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TIE.AX's ROE of +0.02%. Regarding short-term risk, EMR.AX is more volatile compared to TIE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TIE.AX's competition here
EMR.AX vs SXG.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, SXG.AX has a market cap of 764.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while SXG.AX trades at A$3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas SXG.AX's P/E ratio is -86.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SXG.AX's ROE of -0.23%. Regarding short-term risk, EMR.AX is less volatile compared to SXG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SXG.AX's competition here
EMR.AX vs BC8.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BC8.AX has a market cap of 721.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while BC8.AX trades at A$0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BC8.AX's P/E ratio is 46.15. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BC8.AX's ROE of +0.06%. Regarding short-term risk, EMR.AX is more volatile compared to BC8.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check BC8.AX's competition here
EMR.AX vs WC8.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, WC8.AX has a market cap of 715.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while WC8.AX trades at A$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas WC8.AX's P/E ratio is -63.41. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WC8.AX's ROE of -0.02%. Regarding short-term risk, EMR.AX is less volatile compared to WC8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WC8.AX's competition here
EMR.AX vs SBM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, SBM.AX has a market cap of 610.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while SBM.AX trades at A$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas SBM.AX's P/E ratio is -12.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SBM.AX's ROE of -0.11%. Regarding short-term risk, EMR.AX is less volatile compared to SBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SBM.AX's competition here
EMR.AX vs TCG.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TCG.AX has a market cap of 559.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TCG.AX trades at A$0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TCG.AX's P/E ratio is -15.53. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TCG.AX's ROE of -0.22%. Regarding short-term risk, EMR.AX is more volatile compared to TCG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TCG.AX's competition here
EMR.AX vs DTR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, DTR.AX has a market cap of 511.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while DTR.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas DTR.AX's P/E ratio is -28.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DTR.AX's ROE of -0.64%. Regarding short-term risk, EMR.AX is less volatile compared to DTR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DTR.AX's competition here
EMR.AX vs FML.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, FML.AX has a market cap of 487.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while FML.AX trades at A$1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas FML.AX's P/E ratio is 1.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FML.AX's ROE of +0.80%. Regarding short-term risk, EMR.AX is more volatile compared to FML.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check FML.AX's competition here
EMR.AX vs BCN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BCN.AX has a market cap of 368.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while BCN.AX trades at A$3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BCN.AX's P/E ratio is 43.74. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BCN.AX's ROE of +0.11%. Regarding short-term risk, EMR.AX is more volatile compared to BCN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check BCN.AX's competition here
EMR.AX vs MEK.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, MEK.AX has a market cap of 358.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while MEK.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas MEK.AX's P/E ratio is -0.09. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MEK.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to MEK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check MEK.AX's competition here
EMR.AX vs DCN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, DCN.AX has a market cap of 346.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while DCN.AX trades at A$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas DCN.AX's P/E ratio is -5.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DCN.AX's ROE of -0.74%. Regarding short-term risk, EMR.AX is more volatile compared to DCN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check DCN.AX's competition here
EMR.AX vs RXL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RXL.AX has a market cap of 312.7M. Regarding current trading prices, EMR.AX is priced at A$5.46, while RXL.AX trades at A$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RXL.AX's P/E ratio is -18.27. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RXL.AX's ROE of -0.16%. Regarding short-term risk, EMR.AX is more volatile compared to RXL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RXL.AX's competition here
EMR.AX vs ASL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, ASL.AX has a market cap of 301.4M. Regarding current trading prices, EMR.AX is priced at A$5.46, while ASL.AX trades at A$2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas ASL.AX's P/E ratio is -18.05. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ASL.AX's ROE of -0.37%. Regarding short-term risk, EMR.AX is more volatile compared to ASL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ASL.AX's competition here
EMR.AX vs NVA.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, NVA.AX has a market cap of 270.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while NVA.AX trades at A$0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas NVA.AX's P/E ratio is -10.55. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NVA.AX's ROE of -0.16%. Regarding short-term risk, EMR.AX is less volatile compared to NVA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check NVA.AX's competition here
EMR.AX vs ORR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, ORR.AX has a market cap of 267.5M. Regarding current trading prices, EMR.AX is priced at A$5.46, while ORR.AX trades at A$0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas ORR.AX's P/E ratio is -5.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ORR.AX's ROE of -0.49%. Regarding short-term risk, EMR.AX is more volatile compared to ORR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ORR.AX's competition here
EMR.AX vs TBR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TBR.AX has a market cap of 261.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TBR.AX trades at A$5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TBR.AX's P/E ratio is 5.88. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TBR.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is more volatile compared to TBR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TBR.AX's competition here
EMR.AX vs HAV.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, HAV.AX has a market cap of 260.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while HAV.AX trades at A$0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas HAV.AX's P/E ratio is -78.61. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HAV.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is more volatile compared to HAV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check HAV.AX's competition here
EMR.AX vs GCY.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GCY.AX has a market cap of 245.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while GCY.AX trades at A$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GCY.AX's P/E ratio is -1.47. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GCY.AX's ROE of -0.40%. Regarding short-term risk, EMR.AX is more volatile compared to GCY.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GCY.AX's competition here
EMR.AX vs STN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, STN.AX has a market cap of 244.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while STN.AX trades at A$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas STN.AX's P/E ratio is -30.32. In terms of profitability, EMR.AX's ROE is +0.15%, compared to STN.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is more volatile compared to STN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check STN.AX's competition here
EMR.AX vs GG8.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GG8.AX has a market cap of 241.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while GG8.AX trades at A$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GG8.AX's P/E ratio is -33.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GG8.AX's ROE of -0.04%. Regarding short-term risk, EMR.AX is less volatile compared to GG8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GG8.AX's competition here
EMR.AX vs FFX.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, FFX.AX has a market cap of 236.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while FFX.AX trades at A$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas FFX.AX's P/E ratio is -4.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FFX.AX's ROE of +1.76%. Regarding short-term risk, EMR.AX is less volatile compared to FFX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FFX.AX's competition here
EMR.AX vs MGV.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, MGV.AX has a market cap of 227.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while MGV.AX trades at A$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas MGV.AX's P/E ratio is -38.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MGV.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to MGV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MGV.AX's competition here
EMR.AX vs BGD.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BGD.AX has a market cap of 221.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while BGD.AX trades at A$0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BGD.AX's P/E ratio is -38.05. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BGD.AX's ROE of -0.88%. Regarding short-term risk, EMR.AX is more volatile compared to BGD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check BGD.AX's competition here
EMR.AX vs TGM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TGM.AX has a market cap of 219.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TGM.AX trades at A$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TGM.AX's P/E ratio is -64.85. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TGM.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is more volatile compared to TGM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TGM.AX's competition here
EMR.AX vs AS1.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, AS1.AX has a market cap of 214.2M. Regarding current trading prices, EMR.AX is priced at A$5.46, while AS1.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas AS1.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AS1.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is more volatile compared to AS1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AS1.AX's competition here
EMR.AX vs TTM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TTM.AX has a market cap of 208.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TTM.AX trades at A$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TTM.AX's P/E ratio is -14.15. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TTM.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to TTM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TTM.AX's competition here
EMR.AX vs ERM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, ERM.AX has a market cap of 206.2M. Regarding current trading prices, EMR.AX is priced at A$5.46, while ERM.AX trades at A$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas ERM.AX's P/E ratio is -72.97. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ERM.AX's ROE of -0.33%. Regarding short-term risk, EMR.AX is more volatile compared to ERM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ERM.AX's competition here
EMR.AX vs SKY.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, SKY.AX has a market cap of 195.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while SKY.AX trades at A$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas SKY.AX's P/E ratio is -138.89. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SKY.AX's ROE of -0.20%. Regarding short-term risk, EMR.AX is less volatile compared to SKY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SKY.AX's competition here
EMR.AX vs HRZ.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, HRZ.AX has a market cap of 193.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while HRZ.AX trades at A$0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas HRZ.AX's P/E ratio is -10.44. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HRZ.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to HRZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check HRZ.AX's competition here
EMR.AX vs VTM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, VTM.AX has a market cap of 185.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while VTM.AX trades at A$1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas VTM.AX's P/E ratio is -1309.16. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VTM.AX's ROE of -0.26%. Regarding short-term risk, EMR.AX is more volatile compared to VTM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check VTM.AX's competition here
EMR.AX vs HRN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, HRN.AX has a market cap of 183.5M. Regarding current trading prices, EMR.AX is priced at A$5.46, while HRN.AX trades at A$1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas HRN.AX's P/E ratio is -136.24. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HRN.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to HRN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check HRN.AX's competition here
EMR.AX vs BTR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BTR.AX has a market cap of 183M. Regarding current trading prices, EMR.AX is priced at A$5.46, while BTR.AX trades at A$0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BTR.AX's P/E ratio is -97.22. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BTR.AX's ROE of -0.33%. Regarding short-term risk, EMR.AX is more volatile compared to BTR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check BTR.AX's competition here
EMR.AX vs AAR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, AAR.AX has a market cap of 178.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while AAR.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas AAR.AX's P/E ratio is -104.17. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AAR.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to AAR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AAR.AX's competition here
EMR.AX vs MRT.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, MRT.AX has a market cap of 173.4M. Regarding current trading prices, EMR.AX is priced at A$5.46, while MRT.AX trades at A$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas MRT.AX's P/E ratio is -201.52. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MRT.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to MRT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check MRT.AX's competition here
EMR.AX vs LLO.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, LLO.AX has a market cap of 162.5M. Regarding current trading prices, EMR.AX is priced at A$5.46, while LLO.AX trades at A$0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas LLO.AX's P/E ratio is -8.08. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LLO.AX's ROE of -0.16%. Regarding short-term risk, EMR.AX is less volatile compared to LLO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check LLO.AX's competition here
EMR.AX vs BRB.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BRB.AX has a market cap of 158.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while BRB.AX trades at A$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BRB.AX's P/E ratio is 3.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BRB.AX's ROE of +0.05%. Regarding short-term risk, EMR.AX is less volatile compared to BRB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BRB.AX's competition here
EMR.AX vs CY5.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, CY5.AX has a market cap of 153.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while CY5.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas CY5.AX's P/E ratio is -24.04. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CY5.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is more volatile compared to CY5.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check CY5.AX's competition here
EMR.AX vs GBZ.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GBZ.AX has a market cap of 131M. Regarding current trading prices, EMR.AX is priced at A$5.46, while GBZ.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GBZ.AX's P/E ratio is -2.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GBZ.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is less volatile compared to GBZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GBZ.AX's competition here
EMR.AX vs KAU.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, KAU.AX has a market cap of 130.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while KAU.AX trades at A$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas KAU.AX's P/E ratio is 30.15. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KAU.AX's ROE of +0.03%. Regarding short-term risk, EMR.AX is less volatile compared to KAU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KAU.AX's competition here
EMR.AX vs X64.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, X64.AX has a market cap of 129.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while X64.AX trades at A$0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas X64.AX's P/E ratio is -4750.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to X64.AX's ROE of -0.00%. Regarding short-term risk, EMR.AX is more volatile compared to X64.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check X64.AX's competition here
EMR.AX vs RND.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RND.AX has a market cap of 129.7M. Regarding current trading prices, EMR.AX is priced at A$5.46, while RND.AX trades at A$2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RND.AX's P/E ratio is 8.51. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RND.AX's ROE of +0.14%. Regarding short-term risk, EMR.AX is more volatile compared to RND.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RND.AX's competition here
EMR.AX vs LRL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, LRL.AX has a market cap of 125.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while LRL.AX trades at A$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas LRL.AX's P/E ratio is -11.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LRL.AX's ROE of -0.56%. Regarding short-term risk, EMR.AX is more volatile compared to LRL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check LRL.AX's competition here
EMR.AX vs DLI.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, DLI.AX has a market cap of 125.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while DLI.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas DLI.AX's P/E ratio is -46.92. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DLI.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is more volatile compared to DLI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check DLI.AX's competition here
EMR.AX vs TOR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TOR.AX has a market cap of 125.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TOR.AX trades at A$0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TOR.AX's P/E ratio is -28.74. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TOR.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is less volatile compared to TOR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TOR.AX's competition here
EMR.AX vs LSX.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, LSX.AX has a market cap of 124.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while LSX.AX trades at A$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas LSX.AX's P/E ratio is 2.27. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LSX.AX's ROE of +0.38%. Regarding short-term risk, EMR.AX is more volatile compared to LSX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check LSX.AX's competition here
EMR.AX vs TSO.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TSO.AX has a market cap of 124.4M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TSO.AX trades at A$0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TSO.AX's P/E ratio is -1.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TSO.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is more volatile compared to TSO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TSO.AX's competition here
EMR.AX vs KAI.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, KAI.AX has a market cap of 120.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while KAI.AX trades at A$0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas KAI.AX's P/E ratio is -11.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KAI.AX's ROE of -0.26%. Regarding short-term risk, EMR.AX is less volatile compared to KAI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KAI.AX's competition here
EMR.AX vs TUL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TUL.AX has a market cap of 116.6M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TUL.AX trades at A$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TUL.AX's P/E ratio is -2.88. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TUL.AX's ROE of N/A. Regarding short-term risk, EMR.AX is more volatile compared to TUL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TUL.AX's competition here
EMR.AX vs PGL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, PGL.AX has a market cap of 115.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while PGL.AX trades at A$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas PGL.AX's P/E ratio is -8.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PGL.AX's ROE of -0.20%. Regarding short-term risk, EMR.AX is less volatile compared to PGL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PGL.AX's competition here
EMR.AX vs MMC.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, MMC.AX has a market cap of 115.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while MMC.AX trades at A$0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas MMC.AX's P/E ratio is -11.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MMC.AX's ROE of -0.39%. Regarding short-term risk, EMR.AX is more volatile compared to MMC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MMC.AX's competition here
EMR.AX vs BCM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, BCM.AX has a market cap of 108.3M. Regarding current trading prices, EMR.AX is priced at A$5.46, while BCM.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas BCM.AX's P/E ratio is -27.64. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BCM.AX's ROE of -1.92%. Regarding short-term risk, EMR.AX is more volatile compared to BCM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check BCM.AX's competition here
EMR.AX vs AQI.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, AQI.AX has a market cap of 97.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while AQI.AX trades at A$1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas AQI.AX's P/E ratio is -20.16. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AQI.AX's ROE of -0.45%. Regarding short-term risk, EMR.AX is more volatile compared to AQI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AQI.AX's competition here
EMR.AX vs KGD.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, KGD.AX has a market cap of 96M. Regarding current trading prices, EMR.AX is priced at A$5.46, while KGD.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas KGD.AX's P/E ratio is -8.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KGD.AX's ROE of -1.31%. Regarding short-term risk, EMR.AX is less volatile compared to KGD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KGD.AX's competition here
EMR.AX vs CAI.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, CAI.AX has a market cap of 93.7M. Regarding current trading prices, EMR.AX is priced at A$5.46, while CAI.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas CAI.AX's P/E ratio is -3.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CAI.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to CAI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CAI.AX's competition here
EMR.AX vs GBM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GBM.AX has a market cap of 93.3M. Regarding current trading prices, EMR.AX is priced at A$5.46, while GBM.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GBM.AX's P/E ratio is -1.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GBM.AX's ROE of +4.59%. Regarding short-term risk, EMR.AX is less volatile compared to GBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GBM.AX's competition here
EMR.AX vs GPR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GPR.AX has a market cap of 93M. Regarding current trading prices, EMR.AX is priced at A$5.46, while GPR.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GPR.AX's P/E ratio is -5.43. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GPR.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is more volatile compared to GPR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GPR.AX's competition here
EMR.AX vs RC1.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, RC1.AX has a market cap of 90.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while RC1.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas RC1.AX's P/E ratio is -222.22. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RC1.AX's ROE of -0.16%. Regarding short-term risk, EMR.AX is more volatile compared to RC1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RC1.AX's competition here
EMR.AX vs FAL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, FAL.AX has a market cap of 81.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while FAL.AX trades at A$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas FAL.AX's P/E ratio is -9.88. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FAL.AX's ROE of -0.56%. Regarding short-term risk, EMR.AX is less volatile compared to FAL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FAL.AX's competition here
EMR.AX vs GHM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, GHM.AX has a market cap of 81.7M. Regarding current trading prices, EMR.AX is priced at A$5.46, while GHM.AX trades at A$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas GHM.AX's P/E ratio is -23.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GHM.AX's ROE of -0.13%. Regarding short-term risk, EMR.AX is more volatile compared to GHM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GHM.AX's competition here
EMR.AX vs IXR.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, IXR.AX has a market cap of 80.4M. Regarding current trading prices, EMR.AX is priced at A$5.46, while IXR.AX trades at A$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas IXR.AX's P/E ratio is -11.04. In terms of profitability, EMR.AX's ROE is +0.15%, compared to IXR.AX's ROE of -0.31%. Regarding short-term risk, EMR.AX is more volatile compared to IXR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check IXR.AX's competition here
EMR.AX vs TRY.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TRY.AX has a market cap of 78.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TRY.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TRY.AX's P/E ratio is -0.74. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TRY.AX's ROE of +4.97%. Regarding short-term risk, EMR.AX is less volatile compared to TRY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TRY.AX's competition here
EMR.AX vs LAC.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, LAC.AX has a market cap of 73.1M. Regarding current trading prices, EMR.AX is priced at A$5.46, while LAC.AX trades at A$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas LAC.AX's P/E ratio is -23.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LAC.AX's ROE of -0.04%. Regarding short-term risk, EMR.AX is less volatile compared to LAC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check LAC.AX's competition here
EMR.AX vs WMC.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, WMC.AX has a market cap of 72.7M. Regarding current trading prices, EMR.AX is priced at A$5.46, while WMC.AX trades at A$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas WMC.AX's P/E ratio is -6.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WMC.AX's ROE of +0.15%. Regarding short-term risk, EMR.AX is less volatile compared to WMC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WMC.AX's competition here
EMR.AX vs TAM.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, TAM.AX has a market cap of 72.2M. Regarding current trading prices, EMR.AX is priced at A$5.46, while TAM.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas TAM.AX's P/E ratio is -12.55. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TAM.AX's ROE of -0.13%. Regarding short-term risk, EMR.AX is less volatile compared to TAM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TAM.AX's competition here
EMR.AX vs PTN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, PTN.AX has a market cap of 71M. Regarding current trading prices, EMR.AX is priced at A$5.46, while PTN.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas PTN.AX's P/E ratio is -4.80. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PTN.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is more volatile compared to PTN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check PTN.AX's competition here
EMR.AX vs AME.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, AME.AX has a market cap of 69.5M. Regarding current trading prices, EMR.AX is priced at A$5.46, while AME.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas AME.AX's P/E ratio is -9.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AME.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is more volatile compared to AME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AME.AX's competition here
EMR.AX vs KIN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, KIN.AX has a market cap of 67.2M. Regarding current trading prices, EMR.AX is priced at A$5.46, while KIN.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas KIN.AX's P/E ratio is -5.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KIN.AX's ROE of -0.62%. Regarding short-term risk, EMR.AX is less volatile compared to KIN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KIN.AX's competition here
EMR.AX vs CHZ.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, CHZ.AX has a market cap of 65.8M. Regarding current trading prices, EMR.AX is priced at A$5.46, while CHZ.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas CHZ.AX's P/E ratio is -10.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CHZ.AX's ROE of -0.17%. Regarding short-term risk, EMR.AX is more volatile compared to CHZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check CHZ.AX's competition here
EMR.AX vs YRL.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, YRL.AX has a market cap of 61.9M. Regarding current trading prices, EMR.AX is priced at A$5.46, while YRL.AX trades at A$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas YRL.AX's P/E ratio is -8.76. In terms of profitability, EMR.AX's ROE is +0.15%, compared to YRL.AX's ROE of -0.62%. Regarding short-term risk, EMR.AX is more volatile compared to YRL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check YRL.AX's competition here
EMR.AX vs VAN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, VAN.AX has a market cap of 59.2M. Regarding current trading prices, EMR.AX is priced at A$5.46, while VAN.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas VAN.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VAN.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is more volatile compared to VAN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check VAN.AX's competition here
EMR.AX vs AUN.AX Comparison July 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.8B. In comparison, AUN.AX has a market cap of 53.5M. Regarding current trading prices, EMR.AX is priced at A$5.46, while AUN.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 38.00, whereas AUN.AX's P/E ratio is -10.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AUN.AX's ROE of -0.32%. Regarding short-term risk, EMR.AX is more volatile compared to AUN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AUN.AX's competition here